SOPHiA GENETICS to Present at the 2024 RBC Capital Markets Global Healthcare Conference
30 Abril 2024 - 8:05AM
SOPHiA GENETICS, a cloud-native software company and a leader in
data-driven medicine, today announced that Chief Financial Officer
and Chief Operating Officer, Ross Muken, will present at the 2024
RBC Capital Markets Global Healthcare Conference in New York City
on Tuesday, May 14, 2024, at 3:35 p.m. EDT.
The presentation will be webcast live on the SOPHiA
GENETICS Investor Relations website. Additionally, a replay will be
available on the website after its completion.
About SOPHiA GENETICS
SOPHiA GENETICS (Nasdaq: SOPH) is a cloud-native healthcare
technology company on a mission to expand access to data-driven
medicine by using AI to deliver world-class care to patients with
cancer and rare disorders across the globe. It is the creator of
SOPHiA DDM™, a platform that analyzes complex genomic and
multimodal data and generates real-time, actionable insights for a
broad global network of hospital, laboratory, and biopharma
institutions. For more information,
visit SOPHiAGENETICS.COM and connect with us
on LinkedIn.
Investor Contact
Kellen Sanger
IR@sophiagenetics.com
Media Contact
Kelly Katapodis
media@sophiagenetics.com
Sophia Genetics (NASDAQ:SOPH)
Gráfico Histórico do Ativo
De Abr 2024 até Mai 2024
Sophia Genetics (NASDAQ:SOPH)
Gráfico Histórico do Ativo
De Mai 2023 até Mai 2024